Pacer Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-532
| Closed | -$13K | – | 2617 |
|
|
2024
Q2 | $13K | Sell |
532
-628
| -54% | -$15.4K | ﹤0.01% | 3488 |
|
|
2024
Q1 | $24.7K | Buy |
+1,160
| New | +$24.7K | ﹤0.01% | 3402 |
|
|
2021
Q2 | – | Sell |
-2,510
| Closed | -$76K | – | 1496 |
|
|
2021
Q1 | $76K | Sell |
2,510
-396
| -14% | -$12K | ﹤0.01% | 1338 |
|
|
2020
Q4 | $57K | Sell |
2,906
-2,936
| -50% | -$57.6K | ﹤0.01% | 1405 |
|
|
2020
Q3 | $76K | Buy |
+5,842
| New | +$76K | ﹤0.01% | 1283 |
|
|
2018
Q4 | – | Sell |
-5,140
| Closed | -$236K | – | 865 |
|
|
2018
Q3 | $236K | Buy |
+5,140
| New | +$236K | 0.01% | 997 |
|
|
2018
Q2 | – | Sell |
-1,588
| Closed | -$47K | – | 1185 |
|
|
2018
Q1 | $47K | Sell |
1,588
-462
| -23% | -$13.7K | ﹤0.01% | 970 |
|
|
2017
Q4 | $70K | Buy |
+2,050
| New | +$70K | ﹤0.01% | 987 |
|
|
2017
Q3 | – | Sell |
-1,390
| Closed | -$36K | – | 1234 |
|
|
2017
Q2 | $36K | Buy |
+1,390
| New | +$36K | ﹤0.01% | 1136 |
|